These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 24819961)

  • 1. Identification and characterization of a novel small-molecule inhibitor of β-catenin signaling.
    Delgado ER; Yang J; So J; Leimgruber S; Kahn M; Ishitani T; Shin D; Mustata Wilson G; Monga SP
    Am J Pathol; 2014 Jul; 184(7):2111-22. PubMed ID: 24819961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of the Wnt/β-catenin signaling pathway improves the anti-tumor effects of sorafenib against hepatocellular carcinoma.
    Lin HH; Feng WC; Lu LC; Shao YY; Hsu CH; Cheng AL
    Cancer Lett; 2016 Oct; 381(1):58-66. PubMed ID: 27431312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of CREB binding protein-beta-catenin signaling down regulates CD133 expression and activates PP2A-PTEN signaling in tumor initiating liver cancer cells.
    Tang Y; Berlind J; Mavila N
    Cell Commun Signal; 2018 Mar; 16(1):9. PubMed ID: 29530069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The β-catenin/CBP-antagonist ICG-001 inhibits pediatric glioma tumorigenicity in a Wnt-independent manner.
    Wiese M; Walther N; Diederichs C; Schill F; Monecke S; Salinas G; Sturm D; Pfister SM; Dressel R; Johnsen SA; Kramm CM
    Oncotarget; 2017 Apr; 8(16):27300-27313. PubMed ID: 28460484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-tumor Activity of the Small Molecule Inhibitor PRI-724 Against β-Catenin-activated Hepatocellular Carcinoma.
    Gabata R; Harada K; Mizutani Y; Ouchi H; Yoshimura K; Sato Y; Kitao A; Kimura K; Kouji H; Miyashita T; Tajima H; Ohta T
    Anticancer Res; 2020 Sep; 40(9):5211-5219. PubMed ID: 32878809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional and genomic analyses reveal therapeutic potential of targeting β-catenin/CBP activity in head and neck cancer.
    Kartha VK; Alamoud KA; Sadykov K; Nguyen BC; Laroche F; Feng H; Lee J; Pai SI; Varelas X; Egloff AM; Snyder-Cappione JE; Belkina AC; Bais MV; Monti S; Kukuruzinska MA
    Genome Med; 2018 Jul; 10(1):54. PubMed ID: 30029671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tankyrase inhibitors attenuate WNT/β-catenin signaling and inhibit growth of hepatocellular carcinoma cells.
    Ma L; Wang X; Jia T; Wei W; Chua MS; So S
    Oncotarget; 2015 Sep; 6(28):25390-401. PubMed ID: 26246473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Small-molecule inhibition of CBP/catenin interactions eliminates drug-resistant clones in acute lymphoblastic leukemia.
    Gang EJ; Hsieh YT; Pham J; Zhao Y; Nguyen C; Huantes S; Park E; Naing K; Klemm L; Swaminathan S; Conway EM; Pelus LM; Crispino J; Mullighan CG; McMillan M; Müschen M; Kahn M; Kim YM
    Oncogene; 2014 Apr; 33(17):2169-78. PubMed ID: 23728349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of Wnt/β-catenin signaling promotes immune evasion via the β-catenin/IKZF1/CCL5 axis in hepatocellular carcinoma.
    Huang Y; Peng M; Yu W; Li H
    Int Immunopharmacol; 2024 Sep; 138():112534. PubMed ID: 38941667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of canonical WNT signaling pathway by β-catenin/CBP inhibitor ICG-001 ameliorates liver fibrosis in vivo through suppression of stromal CXCL12.
    Akcora BÖ; Storm G; Bansal R
    Biochim Biophys Acta Mol Basis Dis; 2018 Mar; 1864(3):804-818. PubMed ID: 29217140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. β-Catenin Cooperates with CREB Binding Protein to Promote the Growth of Tumor Cells.
    Yu W; Li L; Zheng F; Yang W; Zhao S; Tian C; Yin W; Chen Y; Guo W; Zou L; Deng W
    Cell Physiol Biochem; 2017; 44(2):467-478. PubMed ID: 29141249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RNA-binding motif protein 5 negatively regulates the activity of Wnt/β-catenin signaling in cigarette smoke-induced alveolar epithelial injury.
    Hao YQ; Su ZZ; Lv XJ; Li P; Gao P; Wang C; Bai Y; Zhang J
    Oncol Rep; 2015 May; 33(5):2438-44. PubMed ID: 25738917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Wnt/β-catenin signalling induces MLL to create epigenetic changes in salivary gland tumours.
    Wend P; Fang L; Zhu Q; Schipper JH; Loddenkemper C; Kosel F; Brinkmann V; Eckert K; Hindersin S; Holland JD; Lehr S; Kahn M; Ziebold U; Birchmeier W
    EMBO J; 2013 Jul; 32(14):1977-89. PubMed ID: 23736260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Wnt/β-catenin signaling inhibitor ICG-001 enhances pigmentation of cultured melanoma cells.
    Kim KI; Jeong DS; Jung EC; Lee JH; Kim CD; Yoon TJ
    J Dermatol Sci; 2016 Nov; 84(2):160-168. PubMed ID: 27567978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ICG-001, a novel small molecule regulator of TCF/beta-catenin transcription.
    Eguchi M; Nguyen C; Lee SC; Kahn M
    Med Chem; 2005 Sep; 1(5):467-72. PubMed ID: 16787331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AXIN deficiency in human and mouse hepatocytes induces hepatocellular carcinoma in the absence of β-catenin activation.
    Abitbol S; Dahmani R; Coulouarn C; Ragazzon B; Mlecnik B; Senni N; Savall M; Bossard P; Sohier P; Drouet V; Tournier E; Dumont F; Sanson R; Calderaro J; Zucman-Rossi J; Vasseur-Cognet M; Just PA; Terris B; Perret C; Gilgenkrantz H
    J Hepatol; 2018 Jun; 68(6):1203-1213. PubMed ID: 29525529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Repression of WT1-Mediated LEF1 Transcription by Mangiferin Governs β-Catenin-Independent Wnt Signalling Inactivation in Hepatocellular Carcinoma.
    Tan HY; Wang N; Li S; Hong M; Guo W; Man K; Cheng CS; Chen Z; Feng Y
    Cell Physiol Biochem; 2018; 47(5):1819-1834. PubMed ID: 29953980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The CREB-binding protein inhibitor ICG-001 suppresses pancreatic cancer growth.
    Arensman MD; Telesca D; Lay AR; Kershaw KM; Wu N; Donahue TR; Dawson DW
    Mol Cancer Ther; 2014 Oct; 13(10):2303-14. PubMed ID: 25082960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specific inhibition of CBP/beta-catenin interaction rescues defects in neuronal differentiation caused by a presenilin-1 mutation.
    Teo JL; Ma H; Nguyen C; Lam C; Kahn M
    Proc Natl Acad Sci U S A; 2005 Aug; 102(34):12171-6. PubMed ID: 16093313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. β-Catenin/CBP inhibition alters epidermal growth factor receptor fucosylation status in oral squamous cell carcinoma.
    Chandler KB; Alamoud KA; Stahl VL; Nguyen BC; Kartha VK; Bais MV; Nomoto K; Owa T; Monti S; Kukuruzinska MA; Costello CE
    Mol Omics; 2020 Jun; 16(3):195-209. PubMed ID: 32203567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.